CHANGES MONOCYTE CHEMOATTRACTANTS PROTEIN-1 IN HELICOBACTER PYLORIASSOCIATED GASTRODUODENAL DISEASES

Chemoattractants monocyte protein-1 (MCP-1) is a low molecular weight cytokine, secreted by many cells of the body. The synthesis of MCP-1 can induce the lipopolysaccharides of bacteria, a range of cytokines. It is believed that MCP-1 regulates the migration and infiltration of tissue by monocyte...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	L. V. Matveeva, R. C. Kapkaeva, A. N. Chudajkin, L. S. Mishanina
Formato:	article
Lenguaje:	RU
Publicado:	Sankt-Peterburg : NIIÈM imeni Pastera 2018
Materias:	monocyte chemoattractants protein-1 helicobacter pylori atrophic gastritis gastric ulcer disease gastric cancer Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/82db20bc83714751bb3b2af7824b9cce
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:82db20bc83714751bb3b2af7824b9cce
record_format	dspace
spelling	oai:doaj.org-article:82db20bc83714751bb3b2af7824b9cce2021-11-22T07:09:49ZCHANGES MONOCYTE CHEMOATTRACTANTS PROTEIN-1 IN HELICOBACTER PYLORIASSOCIATED GASTRODUODENAL DISEASES2220-76192313-739810.15789/2220-7619-2018-2-150-156https://doaj.org/article/82db20bc83714751bb3b2af7824b9cce2018-09-01T00:00:00Zhttps://www.iimmun.ru/iimm/article/view/732https://doaj.org/toc/2220-7619https://doaj.org/toc/2313-7398Chemoattractants monocyte protein-1 (MCP-1) is a low molecular weight cytokine, secreted by many cells of the body. The synthesis of MCP-1 can induce the lipopolysaccharides of bacteria, a range of cytokines. It is believed that MCP-1 regulates the migration and infiltration of tissue by monocytes, T-lymphocytes memory, natural killer cells, is involved in differentiation of naive T-helper cells. There is evidence oncogenic and antitumor activity of MCP-1 at different stages of tumor progression. The aim of this work was the determination and comparison of serum level of MCP-1 by infection with Helicobacter (H.) pylori in precancerous conditions and gastric cancer.Material and methods. Surveyed with the informed consent 204 patients with precancerous diseases of the stomach, 40 patients with gastric cancer and 40 healthy volunteers. Patients at esophagogastroduodenoscopy conducted the fence of material for target biopsy for histological and microbiological studies. Blood on the immunoassay climbed in the morning on an empty stomach from the cubital vein in a volume of 5 ml in a vial without preserving agent, the serum was separated by centrifugation for 10 minutes. By ELISA in the serum of patients determined the level of MCP-1, titer of total antibodies to the cytotoxin-associated protein of H. pylori. The obtained data statistically processed.Results. The amount of MCP-1 in serum of the patients significantly exceeded the data of healthy individuals in all groups of comparison. Values of MCP-1 during exacerbation of gastric ulcer was higher than patients with exacerbation of chronic not atrophic and focal atrophic gastritis. The concentration of MCP-1 > 280 pg/ml was detected in 17.6% of patients with pre-cancerous conditions of the stomach. When ulceration process there was a strong direct correlation of the severity of its course and the number of MCP-1 in serum. Serum level of MCP-1 in 5.0% of patients with gastric cancer was at the upper limit of normal values, and 77.5% of patients exceeded it. Indicator in gastric cancer significantly prevailed over the values in precancerous conditions, was correlated with the tumor stage. The level of MCP-1 in serum of the examined healthy volunteers, patients with exacerbation of chronic gastritis, gastric ulcer disease, polyposis, gastric cancer was correlated with the titers of total antibodies to the cytotoxin-associated protein of H. pylori.Conclusion. Determination of serum level of MCP-1 in precancerous conditions and gastric cancer is diagnostically valuable. Comparison of indicator values with the titers of total antibodies to the cytotoxin- associated protein of H. pylori prognostically significant, as it allows to assess the intensity of the induction signal to production of a cytokine.L. V. MatveevaR. C. KapkaevaA. N. ChudajkinL. S. MishaninaSankt-Peterburg : NIIÈM imeni Pasteraarticlemonocyte chemoattractants protein-1helicobacter pyloriatrophic gastritisgastric ulcer diseasegastric cancerInfectious and parasitic diseasesRC109-216RUInfekciâ i Immunitet, Vol 8, Iss 2, Pp 150-156 (2018)
institution	DOAJ
collection	DOAJ
language	RU
topic	monocyte chemoattractants protein-1 helicobacter pylori atrophic gastritis gastric ulcer disease gastric cancer Infectious and parasitic diseases RC109-216
spellingShingle	monocyte chemoattractants protein-1 helicobacter pylori atrophic gastritis gastric ulcer disease gastric cancer Infectious and parasitic diseases RC109-216 L. V. Matveeva R. C. Kapkaeva A. N. Chudajkin L. S. Mishanina CHANGES MONOCYTE CHEMOATTRACTANTS PROTEIN-1 IN HELICOBACTER PYLORIASSOCIATED GASTRODUODENAL DISEASES
description	Chemoattractants monocyte protein-1 (MCP-1) is a low molecular weight cytokine, secreted by many cells of the body. The synthesis of MCP-1 can induce the lipopolysaccharides of bacteria, a range of cytokines. It is believed that MCP-1 regulates the migration and infiltration of tissue by monocytes, T-lymphocytes memory, natural killer cells, is involved in differentiation of naive T-helper cells. There is evidence oncogenic and antitumor activity of MCP-1 at different stages of tumor progression. The aim of this work was the determination and comparison of serum level of MCP-1 by infection with Helicobacter (H.) pylori in precancerous conditions and gastric cancer.Material and methods. Surveyed with the informed consent 204 patients with precancerous diseases of the stomach, 40 patients with gastric cancer and 40 healthy volunteers. Patients at esophagogastroduodenoscopy conducted the fence of material for target biopsy for histological and microbiological studies. Blood on the immunoassay climbed in the morning on an empty stomach from the cubital vein in a volume of 5 ml in a vial without preserving agent, the serum was separated by centrifugation for 10 minutes. By ELISA in the serum of patients determined the level of MCP-1, titer of total antibodies to the cytotoxin-associated protein of H. pylori. The obtained data statistically processed.Results. The amount of MCP-1 in serum of the patients significantly exceeded the data of healthy individuals in all groups of comparison. Values of MCP-1 during exacerbation of gastric ulcer was higher than patients with exacerbation of chronic not atrophic and focal atrophic gastritis. The concentration of MCP-1 > 280 pg/ml was detected in 17.6% of patients with pre-cancerous conditions of the stomach. When ulceration process there was a strong direct correlation of the severity of its course and the number of MCP-1 in serum. Serum level of MCP-1 in 5.0% of patients with gastric cancer was at the upper limit of normal values, and 77.5% of patients exceeded it. Indicator in gastric cancer significantly prevailed over the values in precancerous conditions, was correlated with the tumor stage. The level of MCP-1 in serum of the examined healthy volunteers, patients with exacerbation of chronic gastritis, gastric ulcer disease, polyposis, gastric cancer was correlated with the titers of total antibodies to the cytotoxin-associated protein of H. pylori.Conclusion. Determination of serum level of MCP-1 in precancerous conditions and gastric cancer is diagnostically valuable. Comparison of indicator values with the titers of total antibodies to the cytotoxin- associated protein of H. pylori prognostically significant, as it allows to assess the intensity of the induction signal to production of a cytokine.
format	article
author	L. V. Matveeva R. C. Kapkaeva A. N. Chudajkin L. S. Mishanina
author_facet	L. V. Matveeva R. C. Kapkaeva A. N. Chudajkin L. S. Mishanina
author_sort	L. V. Matveeva
title	CHANGES MONOCYTE CHEMOATTRACTANTS PROTEIN-1 IN HELICOBACTER PYLORIASSOCIATED GASTRODUODENAL DISEASES
title_short	CHANGES MONOCYTE CHEMOATTRACTANTS PROTEIN-1 IN HELICOBACTER PYLORIASSOCIATED GASTRODUODENAL DISEASES
title_full	CHANGES MONOCYTE CHEMOATTRACTANTS PROTEIN-1 IN HELICOBACTER PYLORIASSOCIATED GASTRODUODENAL DISEASES
title_fullStr	CHANGES MONOCYTE CHEMOATTRACTANTS PROTEIN-1 IN HELICOBACTER PYLORIASSOCIATED GASTRODUODENAL DISEASES
title_full_unstemmed	CHANGES MONOCYTE CHEMOATTRACTANTS PROTEIN-1 IN HELICOBACTER PYLORIASSOCIATED GASTRODUODENAL DISEASES
title_sort	changes monocyte chemoattractants protein-1 in helicobacter pyloriassociated gastroduodenal diseases
publisher	Sankt-Peterburg : NIIÈM imeni Pastera
publishDate	2018
url	https://doaj.org/article/82db20bc83714751bb3b2af7824b9cce
work_keys_str_mv	AT lvmatveeva changesmonocytechemoattractantsprotein1inhelicobacterpyloriassociatedgastroduodenaldiseases AT rckapkaeva changesmonocytechemoattractantsprotein1inhelicobacterpyloriassociatedgastroduodenaldiseases AT anchudajkin changesmonocytechemoattractantsprotein1inhelicobacterpyloriassociatedgastroduodenaldiseases AT lsmishanina changesmonocytechemoattractantsprotein1inhelicobacterpyloriassociatedgastroduodenaldiseases
_version_	1718417985874427904

CHANGES MONOCYTE CHEMOATTRACTANTS PROTEIN-1 IN HELICOBACTER PYLORIASSOCIATED GASTRODUODENAL DISEASES

Ejemplares similares